Clinical Trials Logo

Clinical Trial Summary

The aim of this study is to compare the effect of using different doses of ketamine on producing dysphoric reaction.


Clinical Trial Description

Our study is a randomized single-blind observational study. In our study, the effect of producing a dysphoric reaction will be observed by administering ketamine at doses of 0.5 mg/kg and 1 mg/kg to two randomly randomized different groups who presented to our hospital and needed interventional sedation analgesia. For this reason, our patients with an indication for interventional sedation and analgesia will be taken to the observation room and their vital values will be monitored. Two different vascular accesses with at least 18 gauge will be obtained from the two extremities. The patients will be randomized and 0.5 mg/kg IV ketamine will be given to the 1st group. The second group will be given 1 mg/kg IV ketamine. Then, the patients will be recorded in terms of blood pressure, pulse and saturation at the 5th minute, 15th minute and 30th minute. We will give iv ketamine to two different patient groups as 0.5 mg per kilogram in the 1st group and 1 mg per kilogram in the 2nd group and we will observe the patients.We scored the patients between +4 and -5 points on the RASS scale. Patients who were sedated to an extent that they could not be awakened were scored as -5, patients who were dangerously agitated +4, and patients who were awake were scored 0. We considered patients who scored +2 on the Richmond agitation sedation scale as having developed a dysphoric reaction. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05786365
Study type Observational
Source Aksaray University Training and Research Hospital
Contact
Status Active, not recruiting
Phase
Start date January 1, 2023
Completion date December 31, 2023

See also
  Status Clinical Trial Phase
Completed NCT06033729 - Remifentanil Target Controlled Infusion Versus Standard of Care for Conscious Sedation During EBUS-TBNA N/A
Completed NCT04760249 - A Dedicated Sedation Team for Paediatric Procedural Sedation
Recruiting NCT05505279 - Ventilatory Effects of THRIVE During EBUS Phase 3
Recruiting NCT05267704 - Evaluating the Feasibility of VR for Pediatric Renal Biopsies N/A
Active, not recruiting NCT06337877 - Assessment of Sedation Depth in ARDS Patients Undergoing Therapeutic Paralysis
Completed NCT06174168 - The Decisiveness of MFI-11 in Predicting Complications in Patients > 65 Years Who Underwent EBUS-TBNA Under Sedation
Recruiting NCT05969483 - Validation of a Processed EEG Device for Monitoring Sedation in PICU
Recruiting NCT06060626 - Optimization of Sedation Protocol for Endoscopic Procedures Using Impedance Ventilation Monitor. N/A
Recruiting NCT06014138 - Volatile Sedation for Patients With the Acute Respiratory Distress Syndrome Phase 2/Phase 3
Recruiting NCT05958537 - High Flow Nasal Oxygen Cannula in Transcatheter Aortic Valve Replacement: Complications and Biomarkers N/A
Recruiting NCT04801589 - Goal-Directed Sedation in Mechanically Ventilated Infants and Children Phase 3
Completed NCT05748626 - Anti-Snoring Appliances and Airway Manipulation in Patients Undergoing Anesthetic Sedation N/A
Recruiting NCT04727034 - Efficacy and Safety of Remimazolam Tosylate for Sedation in Gastroscopy N/A
Recruiting NCT05407870 - Efficacy and Safety of Etomidate Sedation in Gastric Endoscopic Submucosal Dissection N/A
Not yet recruiting NCT05423821 - Non-operating Room Anesthesia Experiences in Pediatric Magnetic Resonance Imaging Cases
Suspended NCT05399758 - Nociception Evaluated by the NOL® Index in Sedated Patients in the Intensive Care Unit
Completed NCT04410211 - Comparison Between Two Types of Sedation for Elective Upper Endoscopy Procedures N/A
Completed NCT04455776 - Safety Evaluation of Propofol Sedation for Magnetic Resonance Imaging in Pediatric Patients
Completed NCT05451121 - Effect of Sedation Strategy on Duration Mechanical Ventilation in Patient After Cardiac Surgery N/A
Completed NCT05996588 - Comparison Between Sevoflurane and Propofol for Maintenance of Sedation During ERCP Phase 4